These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 9255255
1. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ. Am J Surg Pathol; 1997 Aug; 21(8):922-30. PubMed ID: 9255255 [Abstract] [Full Text] [Related]
3. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Wang HY, Mills SE. Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088 [Abstract] [Full Text] [Related]
8. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Mete O, Kilicaslan I, Gulluoglu MG, Uysal V. Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362 [Abstract] [Full Text] [Related]
9. Immunostaining characteristics of irisin in benign and malignant renal cancers. Kuloğlu T, Artaş G, Yardim M, Sahin I, Aydin Y, Beyoğlu N, Özercan IH, Yalcin MH, Ugur K, Aydin S. Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263 [Abstract] [Full Text] [Related]
10. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN. Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590 [Abstract] [Full Text] [Related]
11. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma. Young JR, Coy H, Kim HJ, Douek M, Lo P, Pantuck AJ, Raman SS. AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273 [Abstract] [Full Text] [Related]
18. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC, Chen PC, Ho DM. Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648 [Abstract] [Full Text] [Related]
19. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Geramizadeh B, Ravanshad M, Rahsaz M. Indian J Pathol Microbiol; 2008 Nov; 51(2):167-71. PubMed ID: 18603673 [Abstract] [Full Text] [Related]
20. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma. Jain S, Roy S, Amin M, Acquafondata M, Yin M, Laframboise W, Bastacky S, Pantanowitz L, Dhir R, Parwani A. Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]